£1.2 million for medical device company

Medical device manufacturer Applied Neurodiagnostics (ANL) has secured £1.2 million in a funding package supplied by North Star Equity Investors, British angel investors and US-based Applied Science Group.


Medical device manufacturer Applied Neurodiagnostics (ANL) has secured £1.2 million in a funding package supplied by North Star Equity Investors, British angel investors and US-based Applied Science Group.

Medical device manufacturer Applied Neurodiagnostics (ANL) has secured £1.2 million in a funding package supplied by North Star Equity Investors, British angel investors and US-based Applied Science Group.

North Star Equity Investors’ co-investment fund supplied £590,000 as part of the deal.

ANL aims to use the funding to manufacture eye-tracking products, which monitor the movement of the eye and can diagnose early-stage neurological disorders.

The investment will enable its devices to undergo clinical trials and commercialisation. ANL is also looking to expand in the UK and develop new products.

Based in Cramlington, Northumberland, the company is already manufacturing eye-tracking devices for the US medical market.

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics